Tapewire

Nasdaq · USD

VRTX

VERTEX PHARMACEUTICALS INC / MA

Export transactions ↓
Tapewire entity
2875
SEC CIK
0000875320
Parsed reports
2,554

Last 12 months

Inside the activity.

0 purchase rows · 93 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202506
Dec 2025016
Jan 202602
Feb 2026049
Mar 202605
Apr 202601
May 202606
Jun 202605
Jul 202603
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 07, 2008 Filed Feb 11, 2008 20:57 UTC
Kelly LisaSVP, Human Resources
GrantStock Option · Derivative 30,500 $0.00 Strike: $18.93 $0.00
Disclosure

SEC source: 0000875320-08-000010 · edgar.xml · derivative · entry 3

Kelly Lisa · CIK 0001349077 · SVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,500

Underlying: Common Stock · 30,500 shares

Expires 2018-02-06

F2 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 02/07/2008, subject to shareholder approval.

Read SEC document
February 07, 2008 Filed Feb 11, 2008 20:57 UTC
Kelly LisaSVP, Human Resources
GrantCommon Stock 8,133 $0.01 $81.33
Disclosure

SEC source: 0000875320-08-000010 · edgar.xml · nonDerivative · entry 1

Kelly Lisa · CIK 0001349077 · SVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,133

F1 · shares: Stock grant made under 2006 Stock and Option Plan, vesting on 2/7/2012, subject to acceleration upon achievement of certain performance-based milestones.

Read SEC document
February 07, 2008 Filed Feb 11, 2008 20:59 UTC
Sachdev AmitSVP, Public Policy,Gov Affairs
GrantStock Option · Derivative 76,250 $0.00 Strike: $18.93 $0.00
Disclosure

SEC source: 0000875320-08-000012 · edgar.xml · derivative · entry 3

Sachdev Amit · CIK 0001406338 · SVP, Public Policy,Gov Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,250

Underlying: Common Stock · 76,250 shares

Expires 2018-02-06

F2 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 02/07/2008, subject to shareholder approval.

Read SEC document
February 07, 2008 Filed Feb 11, 2008 20:59 UTC
Sachdev AmitSVP, Public Policy,Gov Affairs
GrantCommon Stock 10,166 $0.01 $101.66
Disclosure

SEC source: 0000875320-08-000012 · edgar.xml · nonDerivative · entry 1

Sachdev Amit · CIK 0001406338 · SVP, Public Policy,Gov Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,166

F1 · shares: Stock grant made under 2006 Stock and Option Plan, vesting on 2/7/2012, subject to acceleration upon achievement of certain performance-based milestones.

Read SEC document
January 07, 2008 Filed Jan 8, 2008 20:32 UTC Exercise / conversionStock Option · Derivative 40,000 $0.00 Strike: $11.58 $0.00
Disclosure

SEC source: 0000875320-08-000001 · edgar.xml · derivative · entry 2

SACHS BRUCE I · CIK 0001197036 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 40,000 shares

Expires 2008-12-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan. Fully vested.

Read SEC document
January 07, 2008 Filed Jan 8, 2008 20:32 UTC Exercise / conversionCommon Stock 40,000 $11.58 $463,200.00
Disclosure

SEC source: 0000875320-08-000001 · edgar.xml · nonDerivative · entry 1

SACHS BRUCE I · CIK 0001197036 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 12, 2007 Filed Dec 13, 2007 15:39 UTC
POWER JOHANNA MESSINAVP & Controller
SaleCommon Stock 7 $25.45 $178.15
Disclosure

SEC source: 0000875320-07-000122 · edgar.xml · nonDerivative · entry 3

POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,555

F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1.

Read SEC document
December 12, 2007 Filed Dec 13, 2007 15:39 UTC
POWER JOHANNA MESSINAVP & Controller
SaleCommon Stock 1 $25.42 $25.42
Disclosure

SEC source: 0000875320-07-000122 · edgar.xml · nonDerivative · entry 2

POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,562

F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1.

Read SEC document
December 12, 2007 Filed Dec 13, 2007 15:39 UTC
POWER JOHANNA MESSINAVP & Controller
SaleCommon Stock 1 $25.41 $25.41
Disclosure

SEC source: 0000875320-07-000122 · edgar.xml · nonDerivative · entry 1

POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,563

F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1.

Read SEC document
December 11, 2007 Filed Dec 12, 2007 16:22 UTC
ALAM JOHN JEVP, Medicines Dev. & CMO
SaleCommon Stock 45 $25.96 $1,168.20
Disclosure

SEC source: 0000875320-07-000121 · edgar.xml · nonDerivative · entry 8

ALAM JOHN J · CIK 0001197014 · EVP, Medicines Dev. & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,844

F1 · kind: Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1.

Read SEC document
December 11, 2007 Filed Dec 12, 2007 16:22 UTC
ALAM JOHN JEVP, Medicines Dev. & CMO
SaleCommon Stock 50 $25.82 $1,291.00
Disclosure

SEC source: 0000875320-07-000121 · edgar.xml · nonDerivative · entry 7

ALAM JOHN J · CIK 0001197014 · EVP, Medicines Dev. & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,889

F1 · kind: Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1.

Read SEC document
December 11, 2007 Filed Dec 12, 2007 16:22 UTC
ALAM JOHN JEVP, Medicines Dev. & CMO
SaleCommon Stock 45 $25.60 $1,152.00
Disclosure

SEC source: 0000875320-07-000121 · edgar.xml · nonDerivative · entry 6

ALAM JOHN J · CIK 0001197014 · EVP, Medicines Dev. & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,939

F1 · kind: Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1.

Read SEC document
December 11, 2007 Filed Dec 12, 2007 16:22 UTC
ALAM JOHN JEVP, Medicines Dev. & CMO
SaleCommon Stock 140 $25.59 $3,582.60
Disclosure

SEC source: 0000875320-07-000121 · edgar.xml · nonDerivative · entry 5

ALAM JOHN J · CIK 0001197014 · EVP, Medicines Dev. & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,984

F1 · kind: Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1.

Read SEC document
December 11, 2007 Filed Dec 12, 2007 16:22 UTC
ALAM JOHN JEVP, Medicines Dev. & CMO
SaleCommon Stock 50 $25.58 $1,279.00
Disclosure

SEC source: 0000875320-07-000121 · edgar.xml · nonDerivative · entry 4

ALAM JOHN J · CIK 0001197014 · EVP, Medicines Dev. & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,124

F1 · kind: Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1.

Read SEC document
December 11, 2007 Filed Dec 12, 2007 16:22 UTC
ALAM JOHN JEVP, Medicines Dev. & CMO
SaleCommon Stock 50 $25.57 $1,278.50
Disclosure

SEC source: 0000875320-07-000121 · edgar.xml · nonDerivative · entry 3

ALAM JOHN J · CIK 0001197014 · EVP, Medicines Dev. & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,174

F1 · kind: Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1.

Read SEC document
December 11, 2007 Filed Dec 12, 2007 16:22 UTC
ALAM JOHN JEVP, Medicines Dev. & CMO
SaleCommon Stock 50 $25.52 $1,276.00
Disclosure

SEC source: 0000875320-07-000121 · edgar.xml · nonDerivative · entry 2

ALAM JOHN J · CIK 0001197014 · EVP, Medicines Dev. & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,224

F1 · kind: Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1.

Read SEC document
December 11, 2007 Filed Dec 12, 2007 16:22 UTC
ALAM JOHN JEVP, Medicines Dev. & CMO
SaleCommon Stock 50 $25.41 $1,270.50
Disclosure

SEC source: 0000875320-07-000121 · edgar.xml · nonDerivative · entry 1

ALAM JOHN J · CIK 0001197014 · EVP, Medicines Dev. & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,274

F1 · kind: Transaction made pursuant to Dr. Alam's company approved trading plan established under Rule 10b5-1.

Read SEC document
December 07, 2007 Filed Dec 10, 2007 17:16 UTC
BOGER JOSHUA SDirector · President & CEO
Exercise / conversionStock Option · Derivative 17,686 $0.00 Strike: $13.67 $0.00
Disclosure

SEC source: 0000875320-07-000120 · edgar.xml · derivative · entry 11

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,686 shares

Expires 2007-12-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: Fully vested.

Read SEC document
December 07, 2007 Filed Dec 10, 2007 17:16 UTC
BOGER JOSHUA SDirector · President & CEO
SaleCommon Stock 800 $25.34 $20,272.00
Disclosure

SEC source: 0000875320-07-000120 · edgar.xml · nonDerivative · entry 8

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,095,842

F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1.

F8 · kind: Aggregate sales made at prices between $25.25 and $25.39.

Read SEC document
December 07, 2007 Filed Dec 10, 2007 17:16 UTC
BOGER JOSHUA SDirector · President & CEO
SaleCommon Stock 2,186 $25.45 $55,633.70
Disclosure

SEC source: 0000875320-07-000120 · edgar.xml · nonDerivative · entry 7

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,096,642

F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1.

F7 · kind: Aggregate sales made at prices between $25.40 and $25.49.

Read SEC document
December 07, 2007 Filed Dec 10, 2007 17:16 UTC
BOGER JOSHUA SDirector · President & CEO
SaleCommon Stock 2,200 $25.55 $56,210.00
Disclosure

SEC source: 0000875320-07-000120 · edgar.xml · nonDerivative · entry 6

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,098,828

F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1.

F6 · kind: Aggregate sales made at prices between $25.50 and $25.59.

Read SEC document
December 07, 2007 Filed Dec 10, 2007 17:16 UTC
BOGER JOSHUA SDirector · President & CEO
SaleCommon Stock 6,600 $25.64 $169,224.00
Disclosure

SEC source: 0000875320-07-000120 · edgar.xml · nonDerivative · entry 5

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,101,028

F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1.

F5 · kind: Aggregate sales made at prices between $25.60 and $25.69.

Read SEC document
December 07, 2007 Filed Dec 10, 2007 17:16 UTC
BOGER JOSHUA SDirector · President & CEO
SaleCommon Stock 3,400 $25.74 $87,516.00
Disclosure

SEC source: 0000875320-07-000120 · edgar.xml · nonDerivative · entry 4

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,107,628

F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1.

F4 · kind: Aggregate sales made at prices between $25.70 and $25.79.

Read SEC document
December 07, 2007 Filed Dec 10, 2007 17:16 UTC
BOGER JOSHUA SDirector · President & CEO
SaleCommon Stock 1,900 $25.85 $49,115.00
Disclosure

SEC source: 0000875320-07-000120 · edgar.xml · nonDerivative · entry 3

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,111,028

F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1.

F3 · kind: Aggregate sales made at prices between $25.81 and $25.89.

Read SEC document
December 07, 2007 Filed Dec 10, 2007 17:16 UTC
BOGER JOSHUA SDirector · President & CEO
SaleCommon Stock 600 $25.95 $15,570.00
Disclosure

SEC source: 0000875320-07-000120 · edgar.xml · nonDerivative · entry 2

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,112,928

F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1.

F2 · kind: Aggregate sales made at prices between $25.91 and $26.02.

Read SEC document
December 07, 2007 Filed Dec 10, 2007 17:16 UTC
BOGER JOSHUA SDirector · President & CEO
Exercise / conversionCommon Stock 17,686 $13.67 $241,767.62
Disclosure

SEC source: 0000875320-07-000120 · edgar.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,113,528

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 06, 2007 Filed Dec 7, 2007 20:06 UTC
BOGER JOSHUA SDirector · President & CEO
Exercise / conversionStock Option · Derivative 17,500 $0.00 Strike: $13.67 $0.00
Disclosure

SEC source: 0000875320-07-000119 · edgar.xml · derivative · entry 14

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,686

Underlying: Common Stock · 17,500 shares

Expires 2007-12-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F12 · derivative.exercise_date: Fully vested.

Read SEC document
December 06, 2007 Filed Dec 7, 2007 20:06 UTC
BOGER JOSHUA SDirector · President & CEO
SaleCommon Stock 1,200 $25.14 $30,168.00
Disclosure

SEC source: 0000875320-07-000119 · edgar.xml · nonDerivative · entry 11

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,095,842

F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1.

F11 · kind: Aggregate sales made at prices between $25.10 and $25.19.

Read SEC document
December 06, 2007 Filed Dec 7, 2007 20:06 UTC
BOGER JOSHUA SDirector · President & CEO
SaleCommon Stock 800 $25.27 $20,216.00
Disclosure

SEC source: 0000875320-07-000119 · edgar.xml · nonDerivative · entry 10

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,097,042

F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1.

F10 · kind: Aggregate sales made at prices between $25.22 and $25.29.

Read SEC document
December 06, 2007 Filed Dec 7, 2007 20:06 UTC
BOGER JOSHUA SDirector · President & CEO
SaleCommon Stock 900 $25.34 $22,806.00
Disclosure

SEC source: 0000875320-07-000119 · edgar.xml · nonDerivative · entry 9

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,097,842

F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1.

F9 · kind: Aggregate sales made at prices between $25.31 and $25.39.

Read SEC document
December 06, 2007 Filed Dec 7, 2007 20:06 UTC
BOGER JOSHUA SDirector · President & CEO
SaleCommon Stock 4,400 $25.47 $112,068.00
Disclosure

SEC source: 0000875320-07-000119 · edgar.xml · nonDerivative · entry 8

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,098,742

F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1.

F8 · kind: Aggregate sales made at prices between $25.40 and $25.49.

Read SEC document
December 06, 2007 Filed Dec 7, 2007 20:06 UTC
BOGER JOSHUA SDirector · President & CEO
SaleCommon Stock 2,800 $25.53 $71,484.00
Disclosure

SEC source: 0000875320-07-000119 · edgar.xml · nonDerivative · entry 7

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,103,142

F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1.

F7 · kind: Aggregate sales made at prices between $25.50 and $25.58.

Read SEC document
December 06, 2007 Filed Dec 7, 2007 20:06 UTC
BOGER JOSHUA SDirector · President & CEO
SaleCommon Stock 2,500 $25.63 $64,075.00
Disclosure

SEC source: 0000875320-07-000119 · edgar.xml · nonDerivative · entry 6

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,105,942

F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1.

F6 · kind: Aggregate sales made at prices between $25.60 and $25.67.

Read SEC document
December 06, 2007 Filed Dec 7, 2007 20:06 UTC
BOGER JOSHUA SDirector · President & CEO
SaleCommon Stock 1,300 $25.75 $33,475.00
Disclosure

SEC source: 0000875320-07-000119 · edgar.xml · nonDerivative · entry 5

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,108,442

F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1.

F5 · kind: Aggregate sales made at prices between $25.71 and $25.79.

Read SEC document
December 06, 2007 Filed Dec 7, 2007 20:06 UTC
BOGER JOSHUA SDirector · President & CEO
SaleCommon Stock 1,000 $25.84 $25,840.00
Disclosure

SEC source: 0000875320-07-000119 · edgar.xml · nonDerivative · entry 4

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,109,742

F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1.

F4 · kind: Aggregate sales made at prices between $25.81 and $25.89.

Read SEC document
December 06, 2007 Filed Dec 7, 2007 20:06 UTC
BOGER JOSHUA SDirector · President & CEO
SaleCommon Stock 1,900 $25.95 $49,305.00
Disclosure

SEC source: 0000875320-07-000119 · edgar.xml · nonDerivative · entry 3

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,110,742

F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1.

F3 · kind: Aggregate sales made at prices between $25.90 and $25.99.

Read SEC document
December 06, 2007 Filed Dec 7, 2007 20:06 UTC
BOGER JOSHUA SDirector · President & CEO
SaleCommon Stock 700 $26.01 $18,207.00
Disclosure

SEC source: 0000875320-07-000119 · edgar.xml · nonDerivative · entry 2

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,112,642

F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1.

F2 · kind: Aggregate sales made at prices between $26.00 and $26.05.

Read SEC document
December 06, 2007 Filed Dec 7, 2007 20:06 UTC
BOGER JOSHUA SDirector · President & CEO
Exercise / conversionCommon Stock 17,500 $13.67 $239,225.00
Disclosure

SEC source: 0000875320-07-000119 · edgar.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,113,342

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 04, 2007 Filed Dec 5, 2007 17:21 UTC
BOGER JOSHUA SDirector · President & CEO
Exercise / conversionStock Option · Derivative 17,500 $0.00 Strike: $13.67 $0.00
Disclosure

SEC source: 0000875320-07-000118 · edgar.xml · derivative · entry 9

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,186

Underlying: Common Stock · 17,500 shares

Expires 2007-12-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: Fully vested.

Read SEC document
December 04, 2007 Filed Dec 5, 2007 17:21 UTC
BOGER JOSHUA SDirector · President & CEO
SaleCommon Stock 300 $24.74 $7,422.00
Disclosure

SEC source: 0000875320-07-000118 · edgar.xml · nonDerivative · entry 6

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,095,842

F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1.

F6 · kind: Aggregate sales made at prices between $24.72 and $24.77.

Read SEC document
December 04, 2007 Filed Dec 5, 2007 17:21 UTC
BOGER JOSHUA SDirector · President & CEO
SaleCommon Stock 2,700 $24.84 $67,068.00
Disclosure

SEC source: 0000875320-07-000118 · edgar.xml · nonDerivative · entry 5

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,096,142

F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1.

F5 · kind: Aggregate sales made at prices between $24.80 and $24.89.

Read SEC document
December 04, 2007 Filed Dec 5, 2007 17:21 UTC
BOGER JOSHUA SDirector · President & CEO
SaleCommon Stock 5,700 $24.96 $142,272.00
Disclosure

SEC source: 0000875320-07-000118 · edgar.xml · nonDerivative · entry 4

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,098,842

F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1.

F4 · kind: Aggregate sales made at prices between $24.90 and $24.99.

Read SEC document
December 04, 2007 Filed Dec 5, 2007 17:21 UTC
BOGER JOSHUA SDirector · President & CEO
SaleCommon Stock 7,600 $25.04 $190,304.00
Disclosure

SEC source: 0000875320-07-000118 · edgar.xml · nonDerivative · entry 3

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,104,542

F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1.

F3 · kind: Aggregate sales made at prices between $25.00 and $25.09.

Read SEC document
December 04, 2007 Filed Dec 5, 2007 17:21 UTC
BOGER JOSHUA SDirector · President & CEO
SaleCommon Stock 1,200 $25.16 $30,192.00
Disclosure

SEC source: 0000875320-07-000118 · edgar.xml · nonDerivative · entry 2

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,112,142

F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1.

F2 · kind: Aggregate sales made at prices between $25.10 and $25.20.

Read SEC document
December 04, 2007 Filed Dec 5, 2007 17:21 UTC
BOGER JOSHUA SDirector · President & CEO
Exercise / conversionCommon Stock 17,500 $13.67 $239,225.00
Disclosure

SEC source: 0000875320-07-000118 · edgar.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,113,342

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 29, 2007 Filed Nov 30, 2007 19:21 UTC
BOGER JOSHUA SDirector · President & CEO
Exercise / conversionStock Option · Derivative 17,500 $0.00 Strike: $13.67 $0.00
Disclosure

SEC source: 0000875320-07-000117 · edgar.xml · derivative · entry 9

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,686

Underlying: Common Stock · 17,500 shares

Expires 2007-12-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: Fully vested.

Read SEC document
November 29, 2007 Filed Nov 30, 2007 19:21 UTC
BOGER JOSHUA SDirector · President & CEO
SaleCommon Stock 300 $24.76 $7,428.00
Disclosure

SEC source: 0000875320-07-000117 · edgar.xml · nonDerivative · entry 6

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,095,842

F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1.

F6 · kind: Aggregate sales made at prices between $24.75 and $24.79.

Read SEC document
November 29, 2007 Filed Nov 30, 2007 19:21 UTC
BOGER JOSHUA SDirector · President & CEO
SaleCommon Stock 1,489 $24.85 $37,001.65
Disclosure

SEC source: 0000875320-07-000117 · edgar.xml · nonDerivative · entry 5

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,096,142

F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1.

F5 · kind: Aggregate sales made at prices between $24.80 and $24.89.

Read SEC document
November 29, 2007 Filed Nov 30, 2007 19:21 UTC
BOGER JOSHUA SDirector · President & CEO
SaleCommon Stock 7,200 $24.94 $179,568.00
Disclosure

SEC source: 0000875320-07-000117 · edgar.xml · nonDerivative · entry 4

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,097,631

F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1.

F4 · kind: Aggregate sales made at prices between $24.90 and $24.99.

Read SEC document
November 29, 2007 Filed Nov 30, 2007 19:21 UTC
BOGER JOSHUA SDirector · President & CEO
SaleCommon Stock 5,600 $25.05 $140,280.00
Disclosure

SEC source: 0000875320-07-000117 · edgar.xml · nonDerivative · entry 3

BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,104,831

F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1.

F3 · kind: Aggregate sales made at prices between $25.00 and $25.09.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.